For: | Juneja D, Nasa P, Jain R. Liver injury from direct oral anticoagulants. World J Hepatol 2023; 15(6): 841-849 [PMID: 37397936 DOI: 10.4254/wjh.v15.i6.841] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v15/i6/841.htm |
Number | Citing Articles |
1 |
Maria Chiara Pacchiarini, Giuseppe Regolisti, Paolo Greco, Tommaso Di Motta, Giuseppe Daniele Benigno, Marco Delsante, Enrico Fiaccadori, Francesca Di Mario. Treatment of dabigatran intoxication in critically ill patients with Acute Kidney Injury: The role of Sustained Low-Efficiency Dialysis. The International Journal of Artificial Organs 2023; 46(10-11): 574 doi: 10.1177/03913988231204516
|
2 |
Bhesh R Karki, Ranjit B Jasaraj, Suman K Jha, Nodari Maisuradze, Qi Yu. An Uncommon Side Effect of Rivaroxaban: A Drug-Induced Liver Injury. Cureus 2023; doi: 10.7759/cureus.45949
|
3 |
Benjamin Cross, Richard M. Turner, J. Eunice Zhang, Munir Pirmohamed. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?. The Pharmacogenomics Journal 2024; 24(2) doi: 10.1038/s41397-024-00329-y
|
4 |
M. Sudhan, V. Janakiraman, Sheikh F. Ahmad, Sabry M. Attia, Ramasamy Subramanian, Durga Devi, Shiek S. S. J. Ahmed. A comprehensive insight from molecular docking and dynamics with clinical investigation on the impact of direct oral anticoagulants on atheroprotective protein in atrial fibrillation. BMC Pharmacology and Toxicology 2024; 25(1) doi: 10.1186/s40360-024-00785-z
|